Effectiveness of Transformer-Based Large Language Models in Identifying Adverse Drug Reaction Relations from Unstructured Discharge Summaries in Singapore.

Journal: Drug safety
Published Date:

Abstract

INTRODUCTION: Transformer-based large language models (LLMs) have transformed the field of natural language processing and led to significant advancements in various text processing tasks. However, the applicability of these LLMs in identifying related drug-adverse event (AE) pairs within clinical context may be limited by the prevalent use of non-standard sentence structures and grammar.

Authors

  • Yen Ling Koon
    Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
  • Yan Tung Lam
    Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
  • Hui Xing Tan
    Institute of Systems Science, National University of Singapore, 25 Heng Mui Keng Terrace, Singapore, 119615, Singapore. tan.huixing@gmail.com.
  • Desmond Hwee Chun Teo
    Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
  • Jing Wei Neo
    Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
  • Aaron Jun Yi Yap
    Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
  • Pei San Ang
    Vigilance & Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore.
  • Celine Ping Wei Loke
    Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
  • Mun Yee Tham
    Vigilance & Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore.
  • Siew Har Tan
    Vigilance & Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore.
  • Sally Leng Bee Soh
    Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
  • Belinda Qin Pei Foo
    Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
  • Zheng Jye Ling
    Regional Health System Office, National University of Singapore, National University Health System, Singapore, Singapore.
  • James Luen Wei Yip
    Department of Cardiology, National University Heart Centre, Singapore, Singapore.
  • Sreemanee Raaj Dorajoo
    Vigilance & Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore.